Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

VIROPHARMA — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

VIROPHARMA

via HORIZON GOVERNMENT AFFAIRS

2nd Quarter (Apr 1 - June 30) · 2013Posted Feb 18, 2015Filing document ↗LDA record ↗

Income$5Kfee reported

Client

Name: VIROPHARMA
Description: Pharmaceuticals.
Location: Pennsylvania · United States of America

Registrant

Firm: HORIZON GOVERNMENT AFFAIRS
Description: Health Care and Health Care Coverage
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
SBIR opportunities, Medicaid issues
LobbyistsJOEL WHITE · JENNIFER BERNSTEIN
Covered position (JOEL WHITE): Former Staff Director, Ways & Means Health Subcommittee
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.